Inventor · disambiguated record
Mark D. Rosen
Also filed as: ROSEN MARK D
21 granted patents·7 pending applications·80 citations·filing 2004–2023
94Inventor score
Files withJANSSEN PHARMACEUTICA NV20VERGE ANALYTICS INC3AKEBIA THERAPEUTICS INC1BEMBENEK SCOTT D1HOCUTT FRANCES MEREDITH1
Top patents by PatentIndex Score
28 records- 0188US8759345B2Benzoimidazoles as prolyl hydroxylase inhibitorsHOCUTT FRANCES MEREDITH·Filed 2009·Granted Jun 24, 2014·13 cites·12 claims
- 0287US9006251B24-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 14, 2015·7 cites·6 claims
- 0387US8865713B2Benzoimidazoles as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Oct 21, 2014·7 cites·9 claims
- 0486US11618744B2Benzoimidazoles as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Apr 4, 2023·1 cites·8 claims
- 0586US9079866B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 14, 2015·8 cites·7 claims
- 0686US8796263B24-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitorsRABINOWITZ MICHAEL H·Filed 2011·Granted Aug 5, 2014·11 cites·22 claims
- 0785US9073876B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 7, 2015·6 cites·7 claims
- 0882US10975062B24-aminoquinazolinyl compounds as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 13, 2021·1 cites·12 claims
- 0982US9573940B24-aminoquinazolinyl-2-yl-1-pyrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 21, 2017·3 cites·2 claims
- 1081US10246442B24-Aminoquinazolin compounds as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 2, 2019·2 cites·22 claims
- 1180US10851083B2Benzoimidazoles as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Dec 1, 2020·1 cites·4 claims
- 1279US8937078B2Quinazolinones as prolyl hydroxylase inhibitorsBEMBENEK SCOTT D·Filed 2010·Granted Jan 20, 2015·9 cites·13 claims
- 1374US9073923B2Benzoimidazoles as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 7, 2015·1 cites·7 claims
- 1474US7304051B2Quinoxaline compoundsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Dec 4, 2007·6 cites·36 claims
- 1572US9926333B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Mar 27, 2018·1 cites·8 claims
- 1672US9732093B2FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 15, 2017·1 cites·18 claims
- 1771US9884878B2FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 6, 2018·1 cites·6 claims
- 1871US9745328B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 29, 2017·1 cites·16 claims
- 1966US2025340510A1Substituted Phenylbenzenesulfonamide Derivatives and Uses ThereofNINE SQUARE THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 2063US2018215732A9Benzoimidazoles as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2162US7563895B2Quinoxaline compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jul 21, 2009·0 cites·2 claims
- 2260US10047101B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 14, 2018·0 cites·5 claims
- 2358US2016168127A1Benzoimidazoles as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 2457US2015284335A1Benzoimidazoles as prolyl hydroxylase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 2554US2021369678A1Benzimidazole derivative for use in the treatment of inflammatory disordersAKEBIA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2640US2023038929A1Fused Tricyclic Heterocyclic Compounds and Uses ThereofVERGE ANALYTICS INC·Filed 2020·Application pending·0 cites
- 2736US2023146395A1Substituted Pyrimidines and Uses ThereofVERGE ANALYTICS INC·Filed 2021·Application pending·0 cites
- 2827US12486274B2Substituted pyrazolo-pyrimidines and uses thereofVERGE ANALYTICS INC·Filed 2021·Granted Dec 2, 2025·0 cites·29 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →